Bigfoot Biomedical was founded by a team of people with a personal connection to type 1 diabetes. With its Loop and Inject services, the company seeks to reduce the burden of living with insulin-requiring diabetes and to maximize the leverage of health care providers through data, connectivity, automation, and artificial intelligence.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/29/18 | $55,000,000 | Series B |
Abbott Biotech Ventures Cormorant Asset Management Janus Capital JDRF T1D Fund Quadrant Capital Advisors Senvest Capital Senvest Management T1D Exchange Visionnaire Ventures | undisclosed |
| 06/05/20 | $55,000,000 | Series C |
Abbott Biotech Ventures Cormorant Asset Management Janus Henderson Investors Quadrant Capital Advisors Senvest Capital Smile Group | undisclosed |
| 03/19/21 | $57,000,000 | Debt and Equity Financing |
Madryn Asset Management | undisclosed |
